Show simple item record

dc.creatorSweet, Melissaen
dc.date.accessioned2016-01-09T00:09:32Zen
dc.date.available2016-01-09T00:09:32Zen
dc.date.created2003-06-28en
dc.date.issued2003-06-28en
dc.identifierdoi:10.1136/bmj.326.7404.1464-aen
dc.identifier.bibliographicCitationBMJ: British Medical Journal 2003 June 28; 326(7404): 1464en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=IBS+ad+puts+drug+promotion+under+scrutiny&title=BMJ:+British+Medical+Journal+&volume=326&issue=7404&spage=1464&date=2003-06&au=Sweet,+Melissaen
dc.identifier.urihttp://dx.doi.org/10.1136/bmj.326.7404.1464-aen
dc.identifier.urihttp://hdl.handle.net/10822/999542en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:261127en
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationBusiness Ethicsen
dc.titleIBS Ad Puts Drug Promotion Under Scrutinyen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885